184 related articles for article (PubMed ID: 16739355)
21. [Polymorphism of gene promotor region for MMP-2 in rheumatoid arthritis].
Nemec P; Goldbergová M; Swobodnik T; Polásková D; Soucek M; Vasků A
Vnitr Lek; 2006 Apr; 52(4):348-54. PubMed ID: 16755991
[TBL] [Abstract][Full Text] [Related]
22. Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients.
Wiencke K; Louka AS; Spurkland A; Vatn M; Schrumpf E; Boberg KM;
J Hepatol; 2004 Aug; 41(2):209-14. PubMed ID: 15288468
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer.
Oshima T; Kunisaki C; Yoshihara K; Yamada R; Yamamoto N; Sato T; Makino H; Yamagishi S; Nagano Y; Fujii S; Shiozawa M; Akaike M; Wada N; Rino Y; Masuda M; Tanaka K; Imada T
Oncol Rep; 2008 May; 19(5):1285-91. PubMed ID: 18425389
[TBL] [Abstract][Full Text] [Related]
24. The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer.
Hettiaratchi A; Hawkins NJ; McKenzie G; Ward RL; Hunt JE; Wakefield D; Di Girolamo N
Br J Cancer; 2007 Mar; 96(5):783-92. PubMed ID: 17311017
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinase polymorphisms and survival in stage I non-small cell lung cancer.
Heist RS; Marshall AL; Liu G; Zhou W; Su L; Neuberg D; Lynch TJ; Wain J; Christiani DC
Clin Cancer Res; 2006 Sep; 12(18):5448-53. PubMed ID: 17000679
[TBL] [Abstract][Full Text] [Related]
26. Association between the functional polymorphism in the matrix metalloproteinase-7 promoter and susceptibility to adult astrocytoma.
Lu Z; Wang Y; Zhang Q; Zhang X; Wang S; Xie H; Li Y; Jiao B; Zhang J
Brain Res; 2006 Nov; 1118(1):6-12. PubMed ID: 16956593
[TBL] [Abstract][Full Text] [Related]
27. Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer.
Tan W; Wu J; Zhang X; Guo Y; Liu J; Sun T; Zhang B; Zhao D; Yang M; Yu D; Lin D
Carcinogenesis; 2007 Jun; 28(6):1197-201. PubMed ID: 17151091
[TBL] [Abstract][Full Text] [Related]
28. The matrix metalloproteinase-21 gene 572C/T polymorphism and the risk of breast cancer.
Shagisultanova EI; Novikova IA; Sidorenko YS; Marchenko GN; Strongin AY; Malkhosyan SR
Anticancer Res; 2004; 24(1):199-201. PubMed ID: 15015597
[TBL] [Abstract][Full Text] [Related]
29. Serum matrix-metalloproteinase-1 is a bona fide prognostic marker for colorectal cancer.
Tahara K; Mimori K; Iinuma H; Iwatsuki M; Yokobori T; Ishii H; Anai H; Kitano S; Mori M
Ann Surg Oncol; 2010 Dec; 17(12):3362-9. PubMed ID: 20617463
[TBL] [Abstract][Full Text] [Related]
30. A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility.
Tasci AI; Tugcu V; Ozbek E; Ozbay B; Simsek A; Koksal V
BJU Int; 2008 Feb; 101(4):503-7. PubMed ID: 17986285
[TBL] [Abstract][Full Text] [Related]
31. Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression.
Hughes S; Agbaje O; Bowen RL; Holliday DL; Shaw JA; Duffy S; Jones JL
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6673-80. PubMed ID: 18006768
[TBL] [Abstract][Full Text] [Related]
32. No association of MMP-7, MMP-8, and MMP-21 polymorphisms with the risk of hepatocellular carcinoma in a Chinese population.
Qiu W; Zhou G; Zhai Y; Zhang X; Xie W; Zhang H; Yang H; Zhi L; Yuan X; Zhang X; He F
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2514-8. PubMed ID: 18768525
[TBL] [Abstract][Full Text] [Related]
33. The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer.
Gao LB; Rao L; Wang YY; Liang WB; Li C; Xue H; Zhou B; Sun H; Li Y; Lv ML; Du XJ; Zhang L
Carcinogenesis; 2009 Feb; 30(2):295-9. PubMed ID: 19073878
[TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with mortality in haemodialysis patients.
Cozzolino M; Biondi ML; Galassi A; Turri O; Brancaccio D; Gallieni M
Nephrol Dial Transplant; 2009 Jul; 24(7):2207-12. PubMed ID: 19221176
[TBL] [Abstract][Full Text] [Related]
35. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study.
Küry S; Buecher B; Robiou-du-Pont S; Scoul C; Colman H; Le Neel T; Le Houérou C; Faroux R; Ollivry J; Lafraise B; Chupin LD; Sébille V; Bézieau S
BMC Cancer; 2008 Nov; 8():326. PubMed ID: 18992148
[TBL] [Abstract][Full Text] [Related]
36. [Association of TP53 gene polymorphisms with genetic susceptibility to liver metastases of colorectal cancer].
Wang AZ; Zhu ZZ; Cong WM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):168-71. PubMed ID: 18393238
[TBL] [Abstract][Full Text] [Related]
37. A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer.
Shimizu Y; Kondo S; Shirai A; Furukawa M; Yoshizaki T
Auris Nasus Larynx; 2008 Sep; 35(3):381-9. PubMed ID: 18276095
[TBL] [Abstract][Full Text] [Related]
38. Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancer.
Vairaktaris E; Yapijakis C; Vasiliou S; Derka S; Nkenke E; Serefoglou Z; Vorris E; Vylliotis A; Ragos V; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(6B):4095-100. PubMed ID: 18225577
[TBL] [Abstract][Full Text] [Related]
39. PCR analysis of matrix metalloproteinase 3 (MMP-3) gene promoter polymorphism in ovarian cancer.
Smolarz B; Szyłło K; Romanowicz-Makowska H; Niewiadomski M; Kozłowska E; Kulig A
Pol J Pathol; 2003; 54(4):233-8. PubMed ID: 14998290
[TBL] [Abstract][Full Text] [Related]
40. Differences in the gene expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in primary colorectal tumors and their synchronous liver metastases.
Gentner B; Wein A; Croner RS; Zeittraeger I; Wirtz RM; Roedel F; Dimmler A; Dorlaque L; Hohenberger W; Hahn EG; Brueckl WM
Anticancer Res; 2009 Jan; 29(1):67-74. PubMed ID: 19331134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
